Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Grazia Cascio

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Drug and Alcohol Dependence|April 22, 2004
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinenceSara González, Javier Fernández-Ruiz, Vincenzo Di Marzo, et al.
Gastroenterology|July 10, 2002
Endocannabinoids as physiological regulators of colonic propulsion in miceLuisa Pinto, Angelo A Izzo, Maria Grazia Cascio, et al.
Journal of Medicinal Chemistry|April 14, 2009
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probesGiovanni Appendino, Alessia Ligresti, Alberto Minassi, et al.
Journal of Medicinal Chemistry|November 3, 2011
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptorAntonella Brizzi, Maria Grazia Cascio, Maria Frosini, et al.
Biochimica Et Biophysica Acta|February 10, 2006
Development of the first potent and specific inhibitors of endocannabinoid biosynthesisTiziana Bisogno, Maria Grazia Cascio, Bijali Saha, et al.
FEBS Letters|January 13, 2006
First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligandsGiovanni Appendino, Maria Grazia Cascio, Sara Bacchiega, et al.
Journal of Medicinal Chemistry|April 1, 2009
New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivoAntonella Brizzi, Vittorio Brizzi, Maria Grazia Cascio, et al.
Gastroenterology|September 2, 2003
Possible endocannabinoid control of colorectal cancer growthAlessia Ligresti, Tiziana Bisogno, Isabel Matias, et al.
Journal of Medicinal Chemistry|February 26, 2008
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamidesRomano Silvestri, Maria Grazia Cascio, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonistsClementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Drug and Alcohol Dependence|April 22, 2004
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinenceSara González, Javier Fernández-Ruiz, Vincenzo Di Marzo, et al.
Gastroenterology|July 10, 2002
Endocannabinoids as physiological regulators of colonic propulsion in miceLuisa Pinto, Angelo A Izzo, Maria Grazia Cascio, et al.
Journal of Medicinal Chemistry|April 14, 2009
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probesGiovanni Appendino, Alessia Ligresti, Alberto Minassi, et al.
Journal of Medicinal Chemistry|November 3, 2011
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptorAntonella Brizzi, Maria Grazia Cascio, Maria Frosini, et al.
Biochimica Et Biophysica Acta|February 10, 2006
Development of the first potent and specific inhibitors of endocannabinoid biosynthesisTiziana Bisogno, Maria Grazia Cascio, Bijali Saha, et al.
FEBS Letters|January 13, 2006
First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligandsGiovanni Appendino, Maria Grazia Cascio, Sara Bacchiega, et al.
Journal of Medicinal Chemistry|April 1, 2009
New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivoAntonella Brizzi, Vittorio Brizzi, Maria Grazia Cascio, et al.
Gastroenterology|September 2, 2003
Possible endocannabinoid control of colorectal cancer growthAlessia Ligresti, Tiziana Bisogno, Isabel Matias, et al.
Journal of Medicinal Chemistry|February 26, 2008
Synthesis, cannabinoid receptor affinity, and molecular modeling studies of substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamidesRomano Silvestri, Maria Grazia Cascio, Giuseppe La Regina, et al.
Bioorganic & Medicinal Chemistry Letters|October 19, 2007
New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonistsClementina Manera, Maria Grazia Cascio, Veronica Benetti, et al.
Pageof 6